Clinical Implementation of the New MEDRAD XDS Contrast Extravasation Detector for Multidetector Computed Tomography.
Increased speeds of computed tomography (CT) acquisition and concomitant increased intravenous (IV) bolus injection rates have placed patients at greater risk of contrast extravasation. To assess the efficacy of the MEDRAD XDS extravasation detector by recording the incidence of contrast extravasation in high-risk patients during CT angiography. We prospectively collected data on 25 adults ages 45 to 85 years (mean=65 years), all of whom were considered to be at high risk of having a contrast extravasation. All patients underwent CT angiography with power-injected IV contrast injection introduced via an antecubital venous line. Details recorded included patient age and weight, contrast volume, flow rate, maximum injector pressure, image quality, and extravasation incidence and volume. The size of the most commonly used cannula was 20 gauge and the flow rates ranged from 4.0 to 6 mL/second. The XDS device alerted the clinicians to five episodes of extravasation. These were identified at an early stage of the injection with no more than 8 mL of contrast material having been introduced. The utility of this device has been demonstrated and its employment should reduce extravasated contrast volumes with minimum discomfort to high-risk patients.